You're contacting media contact of this press release

Title: Neuralia TMS Provides Proven TMS Therapy to Help Manage Depression

Australia, 19th Nov 2025 - Neuralia TMS, a respected provider of neuromodulation treatments in Melbourne’s inner north, has reaffirmed its commitment to delivering evidence-supported Transcranial Magnetic Stimulation (TMS) therapy for individuals experiencing treatment-resistant depression. The clinic, located at Suite 102/149-155 Pascoe Vale Rd, Moonee Ponds 3039 VIC, continues to operate as a treatment centre offering structured, non-invasive therapeutic programs grounded in current clinical research.TMS therapy has become an established component of modern mental health treatment in Australia, offering an option for individuals for whom conventional interventions have not produced sufficient improvement. The technique uses externally applied magnetic pulses to stimulate specific brain regions involved in mood regulation. This non-invasive approach allows treatment to occur without the use of medication, anaesthesia or surgical procedures, making it suitable for use within regulated outpatient clinical settings such as Neuralia TMS.The clinic's treatment framework reflects the broader movement within mental health care toward diversified therapeutic pathways. Depression represents a complex condition influenced by biological and psychosocial elements, and treatment plans frequently draw on multiple modalities. TMS therapy has become increasingly integrated into multidisciplinary care, supported by published research and an expanding body of clinical experience. Neuralia TMS incorporates this modality within a structured protocol designed to support consistency, safety and adherence to established standards.Dr Shanek Wick, Medical Director at Neuralia TMS, highlighted the clinical importance of offering regulated neuromodulation within the community. “TMS therapy at Ne...

This press release is issued by King Newswire